Quick Takeaways: Why It Matters? CDT’s evaluation agreement with Manoira offers a potential route to repurpose existing clinical-stage assets for veterinary applications, while Manoira could strengthen its planned 2027 launch with differentiated formulations. Any commercial opp...
